Home   >  
Ion Channel/Membrane Transporter
  • Neuro Signaling Pathway
GABA Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

GABA Receptor

Chemical Structure Cat. No. Product Name CAS No.
PR-001 Chemical Structure
BCP49534 PR-001 LY-3884961
PR001 is a gene-replacement therapy that uses adeno-associated virus 9 (AAV9) to deliver a functional copy of the GBA1 gene to the brain.
NS-11394 Chemical Structure
BCP23679 NS-11394 951650-22-9
NS11394 is an orally active and unique subtype-selective GABAA positive allosteric receptor (PAM), with a Ki of ~0.5 nM. NS11394 shows a selectivity profile in the order of GABAA-5 > α3 > α2 > α1-containing receptors. NS11394 has anxiolytic and anti-inflammatory properties.
SL-651498 Chemical Structure
BCP24934 SL-651498 205881-86-3
SL-651498 is a GABAA receptor agonist potentially for the treatment of anxiety.
Furosemide sodium Chemical Structure
BCP48937 Furosemide sodium 41733-55-5
Furosemide sodium is a potent loop diuretic used in the treatment of oedematous states associated with cardiac, renal and hepatic failure, and for the treatment of hypertension.
Nitromazenil Chemical Structure
BCP46523 Nitromazenil 84377-97-9
Nitromazenil is similar to Flumazenil which is an imidazodiazepine that selectively blocks the central effects of classic benzodiazepines.
SSD-114 Chemical Structure
BCP45225 SSD-114 554428-55-6
SSD114 is a novel GABAB receptor positive allosteric modulator.
Rilmazafone Chemical Structure
BCP44486 Rilmazafone 99593-25-6
Rilmazafone is a benzodiazepine (omega) ligand with sedative and hypnotic effects.
Rilmazafone Hydrochloride Chemical Structure
BCP44492 Rilmazafone Hydrochloride 85815-37-8
Rilmazafone hydrochloride is a benzodiazepine (omega) ligand with sedative and hypnotic effects.
FG-7142 Chemical Structure
BCP41880 FG-7142 78538-74-6
FG-7142 is a benzodiazepine receptor ligand with anxiogenic and proconvulsant properties.
CTP-354 Chemical Structure
BCP40162 CTP-354 1213669-91-0
CTP354, also known as C-21191, is a novel deuterated subtype-selective GABA(A) modulator. CTP may be potentially useful for treatment of neuropathic pain, spasticity and anxiety disorders.
123下一页末页共 91 条记录 1 / 10 页